Alicia Turner, MSN, APRN, FNP-C, ACGN
Assistant Professor, Nurse Practitioner, Chief- Division of Genetic Nursing
Positions
- Assistant Professor, Nurse Practitioner, Chief- Division of Genetic Nursing
-
Molecular & Human Genetics/Brendan Lee Lab
Baylor College of Medicine
Houston, TX, US
Addresses
- Texas Childrens Genetics Department (Clinic)
-
Mark Wallace Tower, 16th floor
6701 Fannin Street
Houston, TX, 77030
United States
Phone: (832) 824-7902
aliciat@bcm.edu
- Adult Genetics - Baylor College of Medicine Medical Center (Clinic)
-
McNair Campus
7200 Cambridge St.
Houston, TX, 77030
United States
Phone: (713) 798-7820
Education
- BSN from University of Massachusetts
- 12/2009 - Amherst, Massachusetts, United States
- Nursing
- MSN from University of Texas Medical Branch
- 12/2015 - Galveston, Texas, United States
- Family Nurse Practitioner
- DNP from University of Texas
- 12/2025 - Houston
Certifications
- Certified Family Nurse Practitioner
- American Academy of Nurse Practitioners
- Advanced Practice Registered Nurse (FNP)
- Texas Board of Nursing
- Registered Nurse
- Texas Board of Nursing
- Certified in Clinical Genetics - ACGN
- NPCC
Honors & Awards
- Recipient, 2018 Betsy Love McClung Grant for Research and Education
- American Society for Bone and Mineral Research
- Power of Professionalism Award
- BCM (03/2023)
Professional Interests
- Osteogenesis Imperfecta
- Lysosomal Storage Disorders
- Mucopolysaccharidosis- Hurler Syndrome(MPS I), Hunter Syndrome (MPS II), Sanfilippo Syndrome (MPS III), Morquio Syndrome (MPS IV), Maroteaux-Lamy Syndrome (MPS VI), Sly Syndrome (MPS VII).
- Gaucher Disease
- Fabry Disease
- Pompe Disease
- X-Linked Hypophosphatemia
- Hypophosphatasia
Professional Statement
As a family nurse practitioner, I specialize in genetics and the care of patients across the lifespan at Texas Children's Hospital and Baylor College of Medicine.
Clinically, I see patients in the metabolic and skeletal dysplasia genetics clinics. Diseases I treat include but are not limited to: Lysosomal Storage Disorders (Mucopolysaccharidosis of all types, Gaucher Disease, Pompe Disease, Fabry Disease), Osteogenesis Imperfecta, osteopenia/osteoporosis (including those associated with muscular dystrophies), X-Linked Hypophosphatemia, and Hypophosphatasia.
I manage the infusion service for the Genetics department (TCH and Baylor) which includes enzyme replacement therapy (ERT) for lysosomal storage disorders, bisphosphonates and injectable therapies.
I am a sub-I on the Brittle Bone Disorders Consortium, which aims to improve the lives of those diagnosed with Osteogenesis Imperfecta. Current studies include a natural history study, a biomarker study, and a drug trial underway at this time.
I also dedicate time to the Undiagnosed Disease Network, which seeks to obtain answers for patients who have suffered with diseases for which we lack current diagnosis. Baylor seeks to obtain diagnosis through in-depth testing and advanced genetic methodologies.
Clinically, I see patients in the metabolic and skeletal dysplasia genetics clinics. Diseases I treat include but are not limited to: Lysosomal Storage Disorders (Mucopolysaccharidosis of all types, Gaucher Disease, Pompe Disease, Fabry Disease), Osteogenesis Imperfecta, osteopenia/osteoporosis (including those associated with muscular dystrophies), X-Linked Hypophosphatemia, and Hypophosphatasia.
I manage the infusion service for the Genetics department (TCH and Baylor) which includes enzyme replacement therapy (ERT) for lysosomal storage disorders, bisphosphonates and injectable therapies.
I am a sub-I on the Brittle Bone Disorders Consortium, which aims to improve the lives of those diagnosed with Osteogenesis Imperfecta. Current studies include a natural history study, a biomarker study, and a drug trial underway at this time.
I also dedicate time to the Undiagnosed Disease Network, which seeks to obtain answers for patients who have suffered with diseases for which we lack current diagnosis. Baylor seeks to obtain diagnosis through in-depth testing and advanced genetic methodologies.
Selected Publications
-
Handoko M, Emrick LT, Rosenfeld JA, Wang X, Tran A, Turner A, Belmont JW; Undiagnosed Diseases Network, Lee BH, Bacino CA, Chao HT. " Recurrent mosaic MTOR c.5930C>T (p.Thr1977Ile) Variant Causing Megalencephaly, Asymmetric Polymicrogyria, and Cutaneous Pigmentary Mosaicism (P1.6-037) " Am J Hum Genet. 2019 Mar ; 179 (3) : 475-479.
Pubmed PMID: 30569621. -
Murali CN, Cuthbertson D, Slater B, Nguyen D, Turner A, Harris G, Sutton VR, Lee B; Members of the BBD Consortium, Nagamani SCS.. " Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta " 2019 Nov ;
Pubmed PMID: 31772349. -
Chaya N. Murali, Brady Slater, Salma Musaad, David Cuthbertson, Dianne Nguyen, Alicia Turner, Mahshid Azamian, Laura Tosi, Frank Rauch, V. Reid Sutton, Brendan Lee, Members of the BBD Consortium, Sandesh C. S. Nagamani. " Health‐related Quality of Life in Adults with Osteogenesis Imperfecta " Clinical Genetics. 2021 Feb 12;
Pubmed PMID: 33580568. -
Agustin Leonardo Lujan, Ombretta Foresti, Conor Sugden, Nathalie Brouwers, Alex Mateo Farre, Alessio Vignoli, Mahshid Azamian, Alicia Turner, Jose Wojnacki, Vivek Malhotra. " Defects in Lipid Homeostasis Reflect the Function of TANGO2 in Phospholipid and Neutral Lipid Metabolism " 2023 Mar 24;
Memberships
- American Academy of Nurse Practitioners
- Member
- Houston Area Nurse Practitioners
- Member
- International Society of Nurses in Genetics
- Member
Log In to edit your profile